Literature DB >> 24456045

Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale.

Davide Sabbadin1, Stefano Moro.   

Abstract

Supervised MD (SuMD) is a computational method that allows the exploration of ligand-receptor recognition pathway investigations in a nanosecond (ns) time scale. It consists of the incorporation of a tabu-like supervision algorithm on the ligand-receptor approaching distance into a classic molecular dynamics (MD) simulation technique. In addition to speeding up the acquisition of the ligand-receptor trajectory, this implementation facilitates the characterization of multiple binding events (such as meta-binding, allosteric, and orthosteric sites) by taking advantage of the all-atom MD simulations accuracy of a GPCR-ligand complex embedded into explicit lipid-water environment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24456045     DOI: 10.1021/ci400766b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  34 in total

1.  Computational studies to predict or explain G protein coupled receptor polypharmacology.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Silvia Paoletta
Journal:  Trends Pharmacol Sci       Date:  2014-11-14       Impact factor: 14.819

2.  Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites.

Authors:  Shailesh Kumar Panday; Mattia Sturlese; Veronica Salmaso; Indira Ghosh; Stefano Moro
Journal:  ACS Med Chem Lett       Date:  2019-02-15       Impact factor: 4.345

Review 3.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

4.  Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics.

Authors:  Giuseppe Deganutti; Andrei Zhukov; Francesca Deflorian; Stephanie Federico; Giampiero Spalluto; Robert M Cooke; Stefano Moro; Jonathan S Mason; Andrea Bortolato
Journal:  In Silico Pharmacol       Date:  2017-11-20

5.  Role of extracellular cysteine residues in the adenosine A2A receptor.

Authors:  Elisabetta De Filippo; Vigneshwaran Namasivayam; Lukas Zappe; Ali El-Tayeb; Anke C Schiedel; Christa E Müller
Journal:  Purinergic Signal       Date:  2016-03-11       Impact factor: 3.765

6.  Conserved disulfide bond is not essential for the adenosine A2A receptor: Extracellular cysteines influence receptor distribution within the cell and ligand-binding recognition.

Authors:  Andrea N Naranjo; Amy Chevalier; Gregory D Cousins; Esther Ayettey; Emily C McCusker; Carola Wenk; Anne S Robinson
Journal:  Biochim Biophys Acta       Date:  2014-11-16

7.  Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example.

Authors:  Stephanie Federico; Enrico Margiotta; Silvia Paoletta; Sonja Kachler; Karl-Norbert Klotz; Kenneth A Jacobson; Giorgia Pastorin; Stefano Moro; Giampiero Spalluto
Journal:  Medchemcomm       Date:  2019-02-18       Impact factor: 3.597

8.  Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information.

Authors:  Silvia Paoletta; Davide Sabbadin; Ivar von Kügelgen; Sonja Hinz; Vsevolod Katritch; Kristina Hoffmann; Aliaa Abdelrahman; Jens Straßburger; Younis Baqi; Qiang Zhao; Raymond C Stevens; Stefano Moro; Christa E Müller; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2015-07-21       Impact factor: 3.686

9.  Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.

Authors:  Rebekah L Bower; Lauren Yule; Tayla A Rees; Giuseppe Deganutti; Erica R Hendrikse; Paul W R Harris; Renata Kowalczyk; Zachary Ridgway; Amy G Wong; Katarzyna Swierkula; Daniel P Raleigh; Augen A Pioszak; Margaret A Brimble; Christopher A Reynolds; Christopher S Walker; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2018-04-23

10.  Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor.

Authors:  Giuseppe Deganutti; Kerry Barkan; Barbara Preti; Michele Leuenberger; Mark Wall; Bruno G Frenguelli; Martin Lochner; Graham Ladds; Christopher A Reynolds
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.